1. Hart, P.K. Houston docs found leak in Holy Grail of cancer treatment. Houston Chronicle
http://www.chron.com/news/kilday-hart/article/Hart-Houston-docs-found-leak-in-Holy-Grail-of-3341794.php
(18 February 2012).
2. Institute of Medicine. Evolution of translational omics: lessons learned and the path forward.
http://www.iom.edu/Reports/2012/Evolution-of-Translational-Omics/Report-Brief.aspx
(23 March 2012).
3. US Food and Drug Administration. Device advice: investigational device exemption (IDE).
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance /HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/default.htm
(updated 23 December 2013).
4. Kim, E.S. et al. Cancer Discov. 1, 44–53 (2011).
5. Beckloff Associates, Inc. The regulatory paradox of laboratory developed tests.
http://cardinalhealth.com/beckloff/documents/pdf/TheRegulatoryParadoxofLaboratoryDevelopedTests.pdf
(accessed 12 December 2013).